Calcium Acetate
Product Images NDC 53808-1001

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Calcium Acetate (NDC 53808-1001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Table1)

This is a table showing the adverse reactions in patients with end-stage renal disease undergoing hemodialysis. It reports the total number of adverse reactions for calcium acetate and placebo in a double-blind, placebo-controlled, cross-over study of liquid calcium. The preferred terms listed include nausea, vomiting, and hypercalcemia.*

FDA Label Image

Table 2 (Table2)

Table 2 provides the average serum phosphorous and calcium levels at pre-study, interim, and study completion time points. The values are expressed in mg/dL. A total of ninety-one patients completed at least 6 weeks of the study. The mean and standard error (SE) values are expressed as Vsl. ANOVA test was conducted to check the difference in values at pre-study and study completion, and p-value®<0.001 for phosphorus, indicating a significant difference. For calcium, the p-value® was =0.001, which suggests no significant difference.*

FDA Label Image

Table 3 (Table3)

The text describes Table 3 which shows the levels of serum phosphorous and calcium before and after each treatment arm. The values shown in mean = SEM format indicate that calcium acetate significantly affected the levels of phosphorus and calcium compared to the placebo. The table also includes a p-value obtained after applying ANOVA to the data.*

FDA Label Image

Label Image For 667mg (Calcium Acetate 667mg)

This is a medication called Calcium Acetate. It comes in a capsule form and the strength is 867mg. The bottle contains 30 capsules and is only available through a prescription. The lot number of the medication is 11401259 and it was packaged by DOH Central Pharmacy in Tallahassee, FL. The expiration date is August 30, 2014. There is also a package number/code provided (JPCH 331722377021).*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.